Implantable Collamer Lens Market Outlook (2022-2032)
[250 Pages Report] The global implantable collamer lens market is expected to reach a valuation of US$ 244.8 Mn in 2022. Demand is projected to increase at a CAGR of 13.1% over the forecast period, with the market size reaching US$ 838.2 Mn by 2032.
According to the recent study by Future Market Insights (FMI), the myopia disease indication is leading the market with a share of around 78.2% in the year 2021.
Attributes
Key Insights
Implantable Collamer Lens Market Base Year Value (2021)
US$ 212.9 Million
Estimated Market Size (2022)
US$ 244.8 Million
Projected Market Valuation (2032)
US$ 838.2 Million
Value-based CAGR (2022 to 2032)
13.1%
Key Market Players
STAAR SURGICAL
Implantable collamer lens are an example of a posterior chamber phakic intraocular lens (pIOL). When corneal refractive surgery is not an option with substantial levels of refractive error, pIOL are employed. Faster healing and reversibility are benefits of implantable collamer lens over corneal refractive surgery, because they are less apparent from the outside and pose a lower risk of endothelial cell loss (ECL) due to being positioned farther from the cornea than anterior chamber (AC).
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2017-2021 Implantable Collamer Lens Market Historic Outlook Vs 2022-2032 Forecast
Sales in the implantable collamer lens represented 16.0% of the overall US$ 4.9 Bn worth global intraocular lenses market in 2021.
There are few surgical alternatives available for correcting refractive defect in patients with extreme myopic astigmatism. Patients with low to moderate myopic astigmatism are preferred candidates for corneal refractive procedures including photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK), as these techniques are constrained by corneal thickness and keratometry for safe ablation.
In individuals with severe myopic astigmatism, over-ablation can lead to higher order aberrations and other postoperative problems such corneal ectasia. By dividing the significant refractive correction between a corneal laser ablation and an implantable collamer lens, Bioptics attempts to overcome this constraint.
The U.S. FDA Post Approval Study (PAS) of the Implantable Collamer Lens for Myopia (MICL) has produced long-term data which has added to the current understanding of safety in regard to the occurrence of endothelial cell loss, cataract, and elevated intraocular pressure.
The most popular treatment for correcting refractive defects uses an excimer laser to reshape the cornea, and is known as laser-assisted in situ keratomileusis (LASIK). However, there are restrictions when used to fix high refractive cylinder. The results of LASIK for myopic astigmatism may be affected by the presence of ocular residual astigmatism, discrepancy between refractive and topographic astigmatism axis, and the influence of internal optical astigmatism.
What are the Key Opportunities for the Implantable Collamer Lens Manufacturers?
Currently, using small incision lenticule extraction (SMILE) to treat low to moderate myopia is widely accepted. However, SMILE has its own intrinsic limitations, including thick ablation depths, limited ablation zones, and greater aberrations. SMILE could also raise the risk of haze, corneal ectasia, myopic regression, and dry eye.
The postoperative spherical equivalent error (SER) is observed to be predictable and consistent, making implantable collamer lens (ICL) implantation a promising technique for high myopia correction.
By including patients with thin corneas and even keratoconus, ICL implantation broadened the target population. Studies that compared ICL implantation with SMILE for the treatment of high myopia reached conflicting conclusions. However, widely accepted results of ICL implantation have reportedly outperformed SMILE in terms of higher-order aberrations (HOAs), refractive correctness, and uncorrected distance visual acuity.
Backed by these factors, the adoption of implantable collamer lens is expected to gain traction at a considerable pace.
Find your sweet spots for generating winning opportunities in this market.
Which Factors are Restraining the Demand for Implantable Collamer Lens?
ICL is regarded as a cosmetic procedure, similar to LASIK, and is most likely not covered under insurance coverage. Due to the personalised nature of implants, an ICL is often more expensive per eye than LASIK.
Despite the fact that ICLs are designed to last indefinitely, it is still advised to schedule routine follow-up appointments to make sure the implants are in place and to check for premature cataracts, which could necessitate cataract surgery and raise intraocular pressure. These factors might limit the adoption of ICLs.
Country-wise Insights
What Makes the China Implantable Collamer Lens Market Lucrative?
“Rising Demand for Implantable Contact Lens in China Will Boost Sales”
China dominated the East Asia implantable collamer lens market, accounting for around 46.6% of the total market share in 2021. As per FMI, the trend is expected to continue over the forecast period.
With the approval of STAR SURGICAL’s Visian Implantable Collamer Lens with CentraFLOW technology in China in 2014, the country is witnessing advancements in the field of optical products, which is expected to augment the growth in the market.
What Makes the U.K. Implantable Collamer Lens Market Attractive?
“High Influx of Medical Tourists in the U.K. Will Fuel Sales of Implantable Collamer Lens”
Europe accounted for nearly 26.1% of the global implantable collamer lens market in 2021, with the U.K. emerging as a lucrative pocket. The first implants of the 2011 CE Mark-approved Visian® Implantable Collamer® Lens (ICL(TM)) by STAR SURGICAL were performed in the Europe.
Before the product's complete market debut in the nations that receive CE Mark approvals, these were the initial steps in the company's pre-launch plan for the product at eight sites and 100 eyes.
What is the Japan Implantable Collamer Lens Market Outlook?
“Increasing Adoption of Collamer Lens Surgery in Japan Will Spur Growth”
The Japan implantable collamer lens market held around 17.8% of the global market share in 2021. In Japan, ICL clinical studies began in 2003 and were eventually approved by the Ministry of Health, Labor, and Welfare in 2010.
Prior to the development of Hole ICLs, postoperative complications from glaucoma and cataract surgery were an issue for early ICLs. However, these complications are no longer a problem because of Hole ICLs.
Only ten highly qualified instructors are now authorised to observe and licence the surgery of doctors who desire to operate an ICL in Japan. As a result, demand for implantable collamer lens in Japan is forecast to increase at a considerable pace.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which Indication of Implantable Collamer Lens is Largely in Focus?
“Demand for Implantable Collamer Lens for Myopia Will Remain High”
Based on indication, the myopia segment accounted for 78.2% of the total market share in 2021. Sales in this segment are expected to grow at a 12.6% CAGR over the forecast period. High prevalence of myopic disorders have given way to addressing several indications related to refractive diseases which are highly prevalent globally. The myopic segment of indication is a prime driver for the f implantable collamer lenses market.
Which End User Benefits the Most With the Sales of Implantable Collamer Lens?
“Adoption of Implantable Collamer Lens in Hospital Settings is More Preferred”
In terms of end user, the hospitals segment held 52.4% of the total market share in 2021. Large number of procedures performed with reference to implantable ocular surgeries are undertaken within hospital settings. Prime driver for the same includes the availability of surgical equipment, implants, and the progression of the surgical procedure in the presence of skilled professions.
Competitive Landscape
STAR SURGICAL dominates the market for implantable collamer lenses. Only one posterior chamber phakic IOL (PIOL) has been given FDA marketing and sales approval in the U.S., and that is the implantable collamer lens manufactured by STAAR SURGICAL.
In March 2022, STAAR Surgical announced the U.S. FDA approval of EVO Visian® Implantable Collamer® Lenses.
In April 2022, STAAR Surgical announced first implants of EVO Visian ICL in the U.S.
In June 2022, STAAR Surgical celebrated two million lens milestone for Implantable Collamer® Lens (ICL).
Report Scope as per Implantable Collamer Lens Industry Analysis
Attribute
Details
Estimated Market Size (2022)
US$ 244.8 Million
Projected Market Valuation (2032)
US$ 838.2 Million
Value-based CAGR (2022 to 2032)
13.1%
Forecast Period
2017 to 2021
Historical Data Available for
2022 to 2032
Market Analysis
US$ Mn for Value
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA
Key Market Segments Covered in Implantable Collamer Lens Industry Research
By Indication:
Myopia
Hyperopia
Astigmatism
By End User:
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Eye Research Institutes
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA
Frequently Asked Questions
The global implantable collamer lens market is worth US$ 212.9 Mn in 2021, and is set to expand 3.4X over the next ten years.
The implantable collamer lens market is expected to reach US$ 838.2 Mn by the end of 2032, with sales revenue expected to register 13.1% CAGR.
Growing burden of ocular diseases, rising ageing population, and regulatory approvals of various ophthalmic products, are some of the key trends in this market.
China is the top region which is expected to drive demand for the implantable collamer lens industry.
The U.S. is one of the key markets for implantable collamer lens accounting for about 4.4% of the global implantable collamer lens market in the year 2021.
Demand for implantable collamer lens in Europe is expected to register a growth of 16.2% over the next ten years.
China, Europe, and Japan are the key producers of implantable collamer lens.
STAAR SURGICAL is the key player in the implantable collamer lens industry.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions
3. Key Market Trends
3.1. Demand Side Trends
3.2. Supply Side Trends
4. Key Success Factors
4.1. Disease Epidemiology, by Region
4.2. Product and Technology Assessment
4.3. Regulatory Landscape
4.4. Reimbursement Scenario
4.5. Rise in Demand for Implantable Collamer Lenses
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Rising Geriatric Population
5.2.3. Adoption of LASIK Procedures
5.2.4. Growing Volumes of Refractive Surgery
5.2.5. Cost of Lens Implantation
5.2.6. High Prevalence of Diabetic Population Group
5.2.7. Global Epidemiology of Cataract
5.2.8. Rising Government Support to Control and Treat Blindness
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. Current COVID-19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID-19 and Impact Analysis
6.4.1. By Indication
6.4.2. By End User
6.5. 2021 Market Scenario
7. Global Implantable Collamer Lens Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Indication Type, 2017–2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032
8.3.1. Myopia
8.3.2. Hyperopia
8.3.3. Astigmatism
8.4. Market Attractiveness Analysis By Indication
9. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032
9.3.1. Hospitals
9.3.2. Ophthalmic Clinics
9.3.3. Ambulatory Surgical Centers
9.3.4. Eye Research Institutes
9.4. Market Attractiveness Analysis By End User
10. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
10.3.1. US
10.3.2. Europe
10.3.3. China
10.3.4. Japan
10.3.5. ROW
10.4. Market Attractiveness Analysis By Region
11. U.S. Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
11.3.1. By Indication
11.3.2. By End User
11.4. Market Attractiveness Analysis
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis
12. China Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
12.3.1. By Indication
12.3.2. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Europe Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
13.3.1. By Indication
13.3.2. By End User
13.4. Market Attractiveness Analysis
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. Japan Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
14.3.1. By Indication
14.3.2. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Rest of the World Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
15.3.1. By Indication
15.3.2. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Market Structure Analysis
16.1. Market Analysis by Tier of Companies
16.2. Market Concentration
16.3. Market Share Analysis of Top Players
16.4. Market Presence Analysis
16.4.1. By Regional footprint of Players
16.4.2. Indication footprint of Players
16.4.3. Chanel footprint of Players
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive
17.3.1. STAAR SURGICAL
17.3.1.1. Overview
17.3.1.2. Indication Portfolio
17.3.1.3. Key Financials
17.3.1.4. SWOT Analysis
17.3.1.5. Sales Footprint
17.3.1.6. Analyst Commentary
17.3.1.7. Strategy Overview
17.3.1.7.1. Marketing Strategy
17.3.1.7.2. Indication Strategy
17.3.1.7.3. Channel Strategy
18. Assumptions and Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication
Table 02: Global Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022-2032, By End User
Table 03: Global Implantable Collamer Lens Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Region
Table 04: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 05: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication
Table 06: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 07: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 08: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication
Table 09: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 10: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 11: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication
Table 12: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 13: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 14: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication
Table 15: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 16: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 17: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication
Table 18: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Implantable Collamer Lens Market, By Indication, 2022E
Figure 02: Global Implantable Collamer Lens Market, By End User, 2022E
Figure 03: Global Implantable Collamer Lens Market, By Region, 2022E
Figure 04: Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021
Figure 05: Global Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), Analysis, 2022-2032
Figure 06: Global Implantable Collamer Lens Market Absolute $ Opportunity Analysis, 2022-2032
Figure 07: Global Implantable Collamer Lens Market Analysis by Indication–2022 & 2032
Figure 08: Global Implantable Collamer Lens Market Y-o-Y Growth Projections by Indication, 2022-2032
Figure 09: Global Implantable Collamer Lens Market Attractiveness Analysis, By Indication
Figure 10: Global Implantable Collamer Lens Market Analysis by End User–2022 & 2032
Figure 11: Global Implantable Collamer Lens Market Y-o-Y Growth (%) By End User, 2022-2032
Figure 12: Global Implantable Collamer Lens Market Attractiveness Analysis, By End User
Figure 13: Global Implantable Collamer Lens Market Share Analysis (%) by Region, 2022 & 2032
Figure 14: Global Implantable Collamer Lens Market Y-o-Y Growth (%) by Region, 2022–2032
Figure 15: Global Implantable Collamer Lens Market Attractiveness Analysis, By Region
Figure 16: U.S. Implantable Collamer Lens Market Value Share, By Country (2022F)
Figure 17: U.S. Implantable Collamer Lens Market Value Share, By Indication (2022E)
Figure 18: U.S. Implantable Collamer Lens Market Value Share, By End User (2022E)
Figure 19: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021
Figure 20: U.S. Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 21: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By Indication
Figure 22: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By End User
Figure 23: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By Country
Figure 24: China Implantable Collamer Lens Market Value Share, By Country (2022F)
Figure 25: China Implantable Collamer Lens Market Value Share, By Indication (2022E)
Figure 26: China Implantable Collamer Lens Market Value Share, By End User (2022E)
Figure 27: China Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021
Figure 28: China Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 29: China Implantable Collamer Lens Market Attractiveness Analysis, By Indication
Figure 30: China Implantable Collamer Lens Market Attractiveness Analysis, By End User
Figure 31: China Implantable Collamer Lens Market Attractiveness Analysis, By Country
Figure 32: Europe Implantable Collamer Lens Market Value Share, By Country (2022F)
Figure 33: Europe Implantable Collamer Lens Market Value Share, By Indication (2022E)
Figure 34: Europe Implantable Collamer Lens Market Value Share, By End User (2022E)
Figure 35: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021
Figure 36: Europe Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 37: Europe Implantable Collamer Lens Market Attractiveness Analysis, By Indication
Figure 38: Europe Implantable Collamer Lens Market Attractiveness Analysis, By End User
Figure 39: Europe Implantable Collamer Lens Market Attractiveness Analysis, By Country
Figure 40: Japan Implantable Collamer Lens Market Value Share, By Country (2022F)
Figure 41: Japan Implantable Collamer Lens Market Value Share, By Indication (2022E)
Figure 42: Japan Implantable Collamer Lens Market Value Share, By End User (2022E)
Figure 43: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021
Figure 44: Japan Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 45: Japan Implantable Collamer Lens Market Attractiveness Analysis, By Indication
Figure 46: Japan Implantable Collamer Lens Market Attractiveness Analysis, By End User
Figure 47: Japan Implantable Collamer Lens Market Attractiveness Analysis, By Country
Figure 48: Rest of the World Implantable Collamer Lens Market Value Share, By Country (2022E)
Figure 49: Rest of the World Implantable Collamer Lens Market Value Share, By Indications (2022E)
Figure 50: Rest of the World Implantable Collamer Lens Market Value Share, By End User (2022E)
Figure 51: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021
Figure 52: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 53: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By Indication
Figure 54: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By End User
Figure 55: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By Country
